TNBC - triple-negative breast cancer
Clinical trials for TNBC - triple-negative breast cancer explained in plain language.
Never miss a new study
Get alerted when new TNBC - triple-negative breast cancer trials appear
Sign up with your email to follow new studies for TNBC - triple-negative breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a vaccine stop Triple-Negative breast cancer from coming back?
Vaccine CompletedThis early-phase trial tests an experimental vaccine made from the alpha-lactalbumin protein, found in breast tissue, to see if it can safely train the immune system to fight triple-negative breast cancer cells. The study enrolls people who have completed treatment for non-metast…
Matched conditions: TNBC - TRIPLE-NEGATIVE BREAST CANCER
Early phase 1 • Sponsor: George T. Budd • Aim: Vaccine
Last updated Jul 19, 2026 00:00 UTC
-
Triple-Drug cocktail aims to stall aggressive breast cancer
Disease control CompletedThis phase 2 trial is testing whether a combination of two chemotherapy drugs (nab-paclitaxel and cisplatin) plus an immunotherapy drug (camrelizumab) can help people with metastatic triple-negative breast cancer live longer without their disease getting worse. The study enrolls …
Matched conditions: TNBC - TRIPLE-NEGATIVE BREAST CANCER
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC